Publication:
Assessment of adult women with ovarian masses and treatment of epithelial ovarian cancer: Asco resource-stratified guideline

dc.contributor.authorVerna D. Vanderpuyeen_US
dc.contributor.authorJean Rene V. Clemenceauen_US
dc.contributor.authorSarah Teminen_US
dc.contributor.authorZeba Azizen_US
dc.contributor.authorWilliam M. Burkeen_US
dc.contributor.authorNixon Leonardo Cevallosen_US
dc.contributor.authorLinus T. Chuangen_US
dc.contributor.authorTerence J. Colganen_US
dc.contributor.authorMarcela G. del Carmenen_US
dc.contributor.authorKeiichi Fujiwaraen_US
dc.contributor.authorElise C. Kohnen_US
dc.contributor.authorJose Enrique Gonzáles Nogalesen_US
dc.contributor.authorThomas Okpoti Konneyen_US
dc.contributor.authorAsima Mukhopadhyayen_US
dc.contributor.authorBishnu D. Paudelen_US
dc.contributor.authorIćo Tóthen_US
dc.contributor.authorSarikapan Wilailaken_US
dc.contributor.authorRahel G. Ghebreen_US
dc.contributor.otherRamathibodi Hospitalen_US
dc.contributor.otherSaitama Medical University International Medical Centeren_US
dc.contributor.otherSt. Paul‘s Hospital Millennium Medical Collegeen_US
dc.contributor.otherKomfo Anokye Teaching Hospitalen_US
dc.contributor.otherBir Hospitalen_US
dc.contributor.otherMassachusetts General Hospitalen_US
dc.contributor.otherHospital Angeles del Pedregalen_US
dc.contributor.otherChittaranjan National Cancer Instituteen_US
dc.contributor.otherNational Cancer Institute (NCI)en_US
dc.contributor.otherUniversity of Minnesota Medical Schoolen_US
dc.contributor.otherAmerican Society of Clinical Oncologyen_US
dc.contributor.otherStony Brook University Hospitalen_US
dc.contributor.otherLifeLabsen_US
dc.contributor.otherMallow Flower Foundationen_US
dc.contributor.otherSociedad Lucha Contra Cancer Ecuadoren_US
dc.contributor.otherInstituto Nacional de Cancerologíaen_US
dc.contributor.otherNuvance Healthen_US
dc.contributor.otherHameed Latif Hospitalen_US
dc.contributor.otherKorlebu Teaching Hospitalen_US
dc.contributor.otherNorthern Gynaecological Oncology Centreen_US
dc.date.accessioned2022-08-04T08:14:03Z
dc.date.available2022-08-04T08:14:03Z
dc.date.issued2021-01-01en_US
dc.description.abstractPURPOSE To provide expert guidance to clinicians and policymakers in three resource-constrained settings on diagnosis and staging of adult women with ovarian masses and treatment of patients with epithelial ovarian (including fallopian tube and primary peritoneal) cancer. METHODS A multidisciplinary, multinational ASCO Expert Panel reviewed existing guidelines, conducted a modified ADAPTE process, and conducted a formal consensus process with additional experts. RESULTS Existing sets of guidelines from eight guideline developers were found and reviewed for resourceconstrained settings; adapted recommendations from nine guidelines form the evidence base, informing two rounds of formal consensus; and all recommendations received ≥ 75% agreement. RECOMMENDATIONS Evaluation of adult symptomatic women in all settings includes symptom assessment, family history, and ultrasound and cancer antigen 125 serum tumor marker levels where feasible. In limited and enhanced settings, additional imaging may be requested. Diagnosis, staging, and/or treatment involves surgery. Presurgical workup of every suspected ovarian cancer requires a metastatic workup. Only trained clinicians with logistical support should perform surgical staging; treatment requires histologic confirmation; surgical goal is staging disease and performing complete cytoreduction to no gross residual disease. In first-line therapy, platinum-based chemotherapy is recommended; in advanced stages, patients may receive neoadjuvant chemotherapy. After neoadjuvant chemotherapy, all patients should be evaluated for interval debulking surgery. Targeted therapy is not recommended in basic or limited settings. Specialized interventions are resourcedependent, for example, laparoscopy, fertility-sparing surgery, genetic testing, and targeted therapy. Multidisciplinary cancer care and palliative care should be offered. Additional information can be found at www.asco.org/resource-stratified-guidelines. It is ASCO's view that health care providers and health care system decision makers should be guided by the recommendations for the highest stratum of resources available. The guideline is intended to complement but not replace local guidelines.en_US
dc.identifier.citationJCO Global Oncology. Vol.7, (2021), 1032-1066en_US
dc.identifier.doi10.1200/GO.21.00085en_US
dc.identifier.issn26878941en_US
dc.identifier.other2-s2.0-85110025454en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/76358
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85110025454&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleAssessment of adult women with ovarian masses and treatment of epithelial ovarian cancer: Asco resource-stratified guidelineen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85110025454&origin=inwarden_US

Files

Collections